Headlines Specialties Covid-19 Trending Feeds ASCO20 Videos

Analysis Identifies Immunogenomic Determinants of Response and Survival in RCC

OncLive - David A. Braun, MD, PhD, discusses findings from a pooled analysis of 3 clinical trials evaluating the potential impact of immunophenotypes, somatic mutations, and chromosomal alterations on response to PD-1 inhibition and recurrence in patients with renal cell carcinoma.

Read the full article here

Related Content